Clinical characteristics and genetics analysis for the ITD of congenital hypothyroidism
暂无分享,去创建一个
Y. Kong | N. Yang | L. Gong | Jin-qi Zhao | Hai-he Yang | Yueling Tang | Lulu Li
[1] Carlos P. Modenutti,et al. A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis. , 2021, The Journal of clinical endocrinology and metabolism.
[2] M. Polak,et al. High Diagnostic Yield of Targeted Next-Generation Sequencing in a Cohort of Patients With Congenital Hypothyroidism Due to Dyshormonogenesis , 2021, Frontiers in Endocrinology.
[3] T. Tajima,et al. Targeted next-generation sequencing for congenital hypothyroidism with positive neonatal TSH screening. , 2020, The Journal of clinical endocrinology and metabolism.
[4] H. Targovnik,et al. Defects in protein folding in congenital hypothyroidism , 2019, Molecular and Cellular Endocrinology.
[5] I. Alonso,et al. Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism , 2019, Journal of pediatric endocrinology & metabolism : JPEM.
[6] A. Chiesa,et al. Novel Sodium/Iodide Symporter Compound Heterozygous Pathogenic Variants Causing Dyshormonogenic Congenital Hypothyroidism. , 2019, Thyroid : official journal of the American Thyroid Association.
[7] J. Nicola,et al. Implications of Na+/I- Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy , 2018, Journal of the Endocrine Society.
[8] Carlos P. Modenutti,et al. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter. , 2018, Endocrinology.
[9] A. Kolodkina,et al. High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism , 2018, PloS one.
[10] L. Persani,et al. Genetics and management of congenital hypothyroidism. , 2018, Best practice & research. Clinical endocrinology & metabolism.
[11] A. Sinusas,et al. An extremely high dietary iodide supply forestalls severe hypothyroidism in Na+/I− symporter (NIS) knockout mice , 2017, Scientific Reports.
[12] Cintia E. Citterio,et al. Iodide handling disorders (NIS, TPO, TG, IYD). , 2017, Best practice & research. Clinical endocrinology & metabolism.
[13] M. Mitchell,et al. Unresolved Issues in the Wake of Newborn Screening for Congenital Hypothyroidism. , 2016, The Journal of pediatrics.
[14] S. Fukata,et al. Iodide Transport Defect and Breast Milk Iodine , 2016, European Thyroid Journal.
[15] L. Amzel,et al. Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency. , 2015, The Journal of clinical endocrinology and metabolism.
[16] S. Jhiang,et al. Modulation of Sodium Iodide Symporter in Thyroid Cancer , 2014, Hormones and Cancer.
[17] N. Carrasco,et al. The Na+/I- symporter (NIS): mechanism and medical impact. , 2014, Endocrine reviews.
[18] C. Spitzweg,et al. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations , 2010, Molecular and Cellular Endocrinology.
[19] D. van Nostrand,et al. Radioiodine in the treatment of thyroid cancer. , 2007, Endocrinology and metabolism clinics of North America.
[20] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[21] C. Ginter,et al. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number , 2004, Journal of Cell Science.
[22] N. Amino,et al. Congenital hypothyroidism caused by a mutation in the Na+/l− symporter , 1997, Nature Genetics.
[23] Qing-Rong Liu,et al. Cloning of the human sodium lodide symporter. , 1996, Biochemical and biophysical research communications.
[24] Ari J. Wassner. Congenital Hypothyroidism. , 2018, Clinics in perinatology.
[25] B. Czarnocka. Thyroperoxidase, thyroglobulin, Na(+)/I(-) symporter, pendrin in thyroid autoimmunity. , 2011, Frontiers in bioscience.